Fareon Device for Cognitive Impairment

DP
Overseen ByDavid Putrino, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Icahn School of Medicine at Mount Sinai
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

Who Is on the Research Team?

DP

David Putrino, PhD

Principal Investigator

Icahn School of Medicine at Mount Sinai

Are You a Good Fit for This Trial?

This trial is for people aged 16 or older who speak English and have mild memory or thinking problems linked to conditions like brain injury, Long COVID, chronic fatigue syndrome (ME/CFS), or Alzheimer's. Participants must be able to consent (or have a guardian do so) and attend study visits online or in person.

Inclusion Criteria

* Willing and able to attend all study visits virtually or in person
* English Speaking
My sex or gender does not affect my eligibility.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo at-home MMT treatment for cognitive dysfunction

12 weeks
At-home sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
Assessments at Week 12 and Week 16

What Are the Treatments Tested in This Trial?

Interventions

  • Fareon device

Trial Overview

The study tests the safety and practicality of using the Fareon device—a home-based treatment—for people with cognitive issues from various brain-related conditions. Researchers will monitor how safe it is and gather early data on its effects.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Fareon DeviceExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Icahn School of Medicine at Mount Sinai

Lead Sponsor

Trials
933
Recruited
579,000+